We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.50 | -0.54% | 462.50 | 455.00 | 470.00 | 465.00 | 460.00 | 465.00 | 9,521 | 12:21:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.15 | 219.23M |
From May 2019 to May 2024
TIDMTSTL
RNS Number : 8045N
Tristel PLC
21 May 2015
21 May 2015
Tristel plc
("Tristel" or the "Company")
Trading update
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products provides a trading update for the year ending 30 June 2015.
Tristel addresses three distinct markets: Human Healthcare, Animal Healthcare and Contamination Control, with three distinctively branded product ranges: Tristel, Anistel and Crystel.
The Group has performed ahead of budget in both sales and profit terms over the ten months to 30 April 2015. The strong profit performance can be pinpointed to the Group's direct operations in the UK, Germany and Australasia. Amongst our direct operations, the only disappointing area has been Russia, where the Board continues to review its future prospects.
The Company has raised its internal expectations for the current financial year, and pre-tax profit (before share-based payments) is now expected to be not less than GBP2.5m (2014: GBP1.8m)
Paul Swinney, Chief Executive, comments "The sales momentum that has built within the business over the course of the past two and a half years is being maintained. Our cost base is well controlled and the organisation is dealing well with the execution of our growth strategy. All of this translates to a record profit to be reported for the year".
For further information please contact:
Tristel plc www.tristel.com Paul Swinney, Chief Executive Tel: 01638 721 500 Officer Liz Dixon, Finance Director Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07854 391 303 finnCap Tel: 020 7600 1658 Geoff Nash (Corporate Finance) Charlotte Stranner (Corporate Finance) Stephen Norcross (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLBLFLEEFZBBK
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
